Loading clinical trials...
Loading clinical trials...
A Pilot Study To Design a Clinical Trial That Will Compare the Ability of Plerixafor Alone Versus Plerixafor Plus G-CSF To Generate a Bone Marrow Versus Blood Transplant Product In Normal Healthy Adults
Conditions
Interventions
Plerixafor (Mozobil)
Plerixafor + G-CSF
Locations
1
Canada
Capital Health District Authority
Halifax, Nova Scotia, Canada
Start Date
April 1, 2012
Primary Completion Date
December 1, 2015
Completion Date
December 1, 2015
Last Updated
August 2, 2017
Lead Sponsor
Stephen Couban
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions